Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Superficial vein thrombosis is a challenging venous thromboembolic disorder because of the paucity of randomized controlled trial data and limited guidance in the literature. Despite this, the patient burden is high. Accordingly, clinicians are often left to “fend for themselves”. Very proud of this review in JAMA from my research team that gives clinicians and patients some pathways forward. Our research fellow and a first year medical student at Tufts, Darsiya Krishnathasan, started this as her undergraduate thesis. An incredible effort with amazing guidance from my colleague, Dr. Behnood Bikdeli. ”
Read the full review here.
Title: Superficial Vein Thrombosis: A Review
Authors: Gregory Piazza, Darsiya Krishnathasan, Nada Hamade, Francisco Ujueta, Giovanni Scimeca, Marcos D. Ortiz-Rios, Bridget McGonagle, Jean-Philippe Galanaud, David Jiménez, Manuel Monreal, John Fanikos, Anahita Dua, Leben Tefera, Raghu Kolluri, Sahil A. Parikh, Walter Ageno, Samuel Z. Goldhaber, Jeffrey I. Weitz, Lisa K. Moores, Isabelle Quéré, Behnood Bikdeli
Stay updated with Hemostasis Today.
-
Oct 9, 2025, 19:53Wilfried Dinh: Top 10 Thrombosis And Antithrombotic Therapy Papers Of 2024
-
Oct 9, 2025, 13:12Abdul Mannan - Ferritin After IV Iron: Timing Matters
-
Oct 9, 2025, 13:11William Aird: Understanding the Ferritin Surge After IV Iron
-
Oct 9, 2025, 13:07World Thrombosis Day: The Silent Threat Of Blood Clots Doesn't Discriminate
-
Oct 9, 2025, 13:01Dr. Abigail Amankwa-Boateng Highlights the Hidden Risk of Venous Thromboembolism in Children
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 01:58Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
-
Oct 9, 2025, 13:08Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
-
Oct 9, 2025, 12:59WFH: Insights From the Prospective Rare Bleeding Disorders Database
-
Oct 9, 2025, 12:58Andrew Jackson: Recurrent Catheter-Related Right Atrial Thrombosis in a Hemodialysis Patient
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic